Literature DB >> 18843006

Increased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in Taiwan.

Kuan-Der Lee1, Shin-Cheh Chen, Chunghuang Hubert Chan, Chang-Hsien Lu, Chih-Cheng Chen, Jen-Tsun Lin, Miao-Fen Chen, Shih-Hao Huang, Chun-Ming Yeh, Min-Chi Chen.   

Abstract

Studies conducted in Western countries have reported excess risks for second primary malignancies after breast cancer. However, there is little documentation of ethnic differences in these excess risks. Asian women are characterized by younger age at diagnosis of breast cancer, but very few reports are available on the incidences and risks for second primary cancers in this region. Using population-based data from the Taiwan National Cancer Registry (TNCR) for the period 1979 to 2003, we quantified standardized incidence ratios and cumulative incidence of second cancers among 53,783 women with initial diagnoses of breast cancer. Age-specific incidences showed peaks among women in their 40s, and 1,085 cases (2.02%) developed nonbreast second primary cancers. The risk for second cancers differs significantly according to age at diagnosis of breast cancer. In comparison with women diagnosed when >or=50 years (standardized incidence ratio, 0.96; 95% confidence interval; 0.89-1.04), there were significantly greater risks for bone, corpus uterine, ovarian, thyroid, esophageal, kidney and lung cancers, nonmelanoma skin cancer, and leukemia or lymphoma in women diagnosed when <50 years (standardized incidence ratio, 1.43; 95% confidence interval, 1.29-1.58). The survival probabilities differed between breast cancer patients with and without second cancers (P<0.001). After diagnosis of the second cancer, the median survival time was only 2.87 years. In conclusion, we confirmed that young age at diagnosis of breast cancer predicted a subsequently increased risk for second malignancies, and the second cancers indeed worsen survivorship in patients who survived breast cancer.

Entities:  

Mesh:

Year:  2008        PMID: 18843006     DOI: 10.1158/1055-9965.EPI-08-0109

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  29 in total

1.  Acute promyelocytic leukemia in a young patient with breast cancer.

Authors:  Ozgur Kara; Evren Ozdemir; Cagatay Arslan; Erkan Dogan; Kadri Altundag
Journal:  Med Oncol       Date:  2010-02-06       Impact factor: 3.064

2.  Clinical presentations of thyroid cancer patients with multiple primary cancers.

Authors:  J D Lin; K J Lin; T C Chao; C Hseuh; N M Tsang; B Y Huang
Journal:  J Endocrinol Invest       Date:  2011-05-24       Impact factor: 4.256

3.  Risk of treatment-related esophageal cancer among breast cancer survivors.

Authors:  L M Morton; E S Gilbert; P Hall; M Andersson; H Joensuu; L Vaalavirta; G M Dores; M Stovall; E J Holowaty; C F Lynch; R E Curtis; S A Smith; R A Kleinerman; M Kaijser; H H Storm; E Pukkala; R E Weathers; M S Linet; P Rajaraman; J F Fraumeni; L M Brown; F E van Leeuwen; S D Fossa; T B Johannesen; F Langmark; S Lamart; L B Travis; B M P Aleman
Journal:  Ann Oncol       Date:  2012-06-27       Impact factor: 32.976

Review 4.  The Breast-Thyroid Cancer Link: A Systematic Review and Meta-analysis.

Authors:  Sarah M Nielsen; Michael G White; Susan Hong; Briseis Aschebrook-Kilfoy; Edwin L Kaplan; Peter Angelos; Swati A Kulkarni; Olufunmilayo I Olopade; Raymon H Grogan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-02       Impact factor: 4.254

5.  Therapy related acute myeloid leukemia in breast cancer survivors, a population-based study.

Authors:  Mike G Martin; John S Welch; Jingqin Luo; Matthew J Ellis; Timothy A Graubert; Matthew J Walter
Journal:  Breast Cancer Res Treat       Date:  2009-03-26       Impact factor: 4.872

6.  Survival impact of locoregional metachronous malignancy in survival of lung cancer patients who received curative treatment.

Authors:  Chi-Tsung Wen; Jui-Ying Fu; Ching-Feng Wu; Ming-Ju Hsieh; Yun-Hen Liu; Yi-Cheng Wu; Ying-Huang Tsai; Ching-Yang Wu
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

Review 7.  Breast cancer before age 40 years.

Authors:  Carey K Anders; Rebecca Johnson; Jennifer Litton; Marianne Phillips; Archie Bleyer
Journal:  Semin Oncol       Date:  2009-06       Impact factor: 4.929

8.  Thyroid disease is associated with an increased risk of breast cancer: a systematic review and meta-analysis.

Authors:  Shi Chen; Fei Wu; Rui Hai; Qian You; Linjun Xie; Liang Shu; Xiangyu Zhou
Journal:  Gland Surg       Date:  2021-01

Review 9.  Epidemiology and clinicopathological features of lung cancer in patients with prior history of breast cancer.

Authors:  Kevin Y Wang; James Newman; Chung-Shien Lee; Nagashree Seetharamu
Journal:  SAGE Open Med       Date:  2021-05-25

10.  Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study.

Authors:  Qing-An Zeng; Jiliang Qiu; Ruhai Zou; Yijie Li; Shengping Li; Binkui Li; Pinzhu Huang; Jian Hong; Yun Zheng; Xiangming Lao; Yunfei Yuan
Journal:  BMC Cancer       Date:  2012-04-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.